NASDAQ:ICCC
ImmuCell Corporation Stock News
$4.91
-0.190 (-3.73%)
At Close: Apr 30, 2024
ImmuCell Announces Refinancing of its Bank Debt
08:05pm, Wednesday, 11'th Mar 2020
ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that im
Stocks That Hit 52-Week Lows On Wednesday
03:41pm, Wednesday, 11'th Mar 2020
During Wednesday's morning session, 690 stocks hit new 52-week lows.
Intriguing Points:
Boeing (NYSE: BA) was the biggest company on a market cap basis to set a new...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Bi
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...
Why ImmuCell Corporation's (NASDAQ:ICCC) CEO Pay Matters To You
02:09pm, Sunday, 01'st Mar 2020
In 2000 Michael Brigham was appointed CEO of ImmuCell Corporation (NASDAQ:ICCC). This report will, first, examine the...
NVAX, SGMO among premarket gainers
02:20pm, Friday, 28'th Feb 2020
Dynatronics (NASDAQ:DYNT) +224%.Altimmune (NASDAQ:ALT) +143% on completing first development milestone toward a single-dose intranasal COVID-19 vaccine.Allied Healthcare Products (NASDAQ:AHPI) +103%
Edited Transcript of ICCC earnings conference call or presentation 19-Feb-20 2:00pm GMT
06:09am, Wednesday, 26'th Feb 2020
Full Year 2019 ImmuCell Corp Earnings Call
ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($0.06) to ($0.04) for the Quarter Ended December 31, 2019
05:35pm, Wednesday, 19'th Feb 2020
PORTLAND, Maine, Feb. 19, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets.
24 Stocks Moving in Wednesday's Pre-Market Session
12:29pm, Wednesday, 19'th Feb 2020
Gainers
Viveve Medical, Inc (NASDAQ: VIVE) shares rose 22.8% to $1.67 in pre-market trading after climbing 15.25% on Tuesday.
Shotspotter Inc (NASDAQ: SSTI) shares rose 20.1% to...
The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
12:21pm, Wednesday, 19'th Feb 2020
Here's a roundup of top developments in the … Full story available on Benzinga.com
ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($…. ...
12:00am, Wednesday, 19'th Feb 202012 Stocks Moving In Tuesday's After-Hours Session
09:59pm, Tuesday, 18'th Feb 2020
Gainers
ShotSpotter (NASDAQ: SSTI) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results. The company also reaffirmed FY20...